Sales of pediatric prophylactic vaccines are projected to increase from $3.3 billion to $5 billion by 2006, for example, with sales of similar drugs for adults to increase from $2.3 billion to $3.8 billion, according to the BCCI statement. "In my role in keeping an eye on my competitors, it's reasonable to assume that there is intense work in the industry and [it is] becoming more and more important in the future," says Lee Mizzen, vice president of scientific affairs at StressGen, a Victoria, British Columbia-based biotechnology company developing vaccines to treat cancer and viral infections. David Jensen, founder and principal consultant of Searchmasters International of Sedona, Ariz., says, "We're seeing resurgence of vaccine interest, not only from traditional companies, but we have been retained by a private foundation to find key people in the development of an AIDS vaccine." Therapeutic vaccines, however, will still remain a relatively small part ...
Profession Notes
The old PhD career path: Get the degree. Teach. The new PhD career path: Get the degree. Teach, but only if nothing better comes along. A majority of science and engineering doctorate holders have forsaken careers in academia, even though they started out on a teaching track, according to "Academic Employment of Recent Science and Engineering Doctorate Holders." Fewer of those who opt for academia want to share their knowledge with students. "Although a sizeable majority [64 percent] of recent [
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
